0001104659-19-047536.txt : 20190827
0001104659-19-047536.hdr.sgml : 20190827
20190827172704
ACCESSION NUMBER: 0001104659-19-047536
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190823
FILED AS OF DATE: 20190827
DATE AS OF CHANGE: 20190827
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Khattar Jack A.
CENTRAL INDEX KEY: 0001539937
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35518
FILM NUMBER: 191058549
MAIL ADDRESS:
STREET 1: C/O SUPERNUS PHARMACEUTICALS, INC.
STREET 2: 1550 EAST GUDE DRIVE
CITY: ROCKVILLE
STATE: MD
ZIP: 20850
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: SUPERNUS PHARMACEUTICALS, INC.
CENTRAL INDEX KEY: 0001356576
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
BUSINESS ADDRESS:
STREET 1: 1550 E GUDE DR
CITY: ROCKVILLE
STATE: MD
ZIP: 20850
BUSINESS PHONE: 301-838-2500
MAIL ADDRESS:
STREET 1: 1550 E GUDE DR
CITY: ROCKVILLE
STATE: MD
ZIP: 20850
FORMER COMPANY:
FORMER CONFORMED NAME: SUPERNUS PHARMACEUTICALS INC
DATE OF NAME CHANGE: 20060317
4
1
a4.xml
4
X0306
4
2019-08-23
0
0001356576
SUPERNUS PHARMACEUTICALS, INC.
SUPN
0001539937
Khattar Jack A.
C/O SUPERNUS PHARMACEUTICALS, INC.
1550 EAST GUDE STREET
ROCKVILLE
MD
20850
1
1
0
0
President, CEO
Common Stock
2019-08-23
4
P
0
7200
26.3864
A
465141
D
Common Stock
1081450
I
By the KBT Trust
Common Stock
2900
I
By son
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $26.0000 to $26.5100, inclusive. The reporting person undertakes to provide to Supernus Pharmaceuticals, Inc. ("Supernus"), any security holder of Supernus, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (1) to this Form 4.
Includes an aggregate of 376 shares acquired by the Reporting Person through the Issuer's Employee Stock Purchase Plan subsequent to the date of the Reporting Person's most recent filing on Form 4.
The Reporting Person disclaims beneficial ownership of the shares held by his son, who shares the Reporting Person's household, and this report should not be deemed an admission that the Reporting Person is the beneficial owner of his son's shares for purposes of Section 16 or for any other purpose.
/s/ Gregory S. Patrick, as attorney-in-fact
2019-08-27